PL2044076T3 - Sposób wytwarzania asenapiny i związki pośrednie do stosowania w tym sposobie - Google Patents
Sposób wytwarzania asenapiny i związki pośrednie do stosowania w tym sposobieInfo
- Publication number
- PL2044076T3 PL2044076T3 PL07801417T PL07801417T PL2044076T3 PL 2044076 T3 PL2044076 T3 PL 2044076T3 PL 07801417 T PL07801417 T PL 07801417T PL 07801417 T PL07801417 T PL 07801417T PL 2044076 T3 PL2044076 T3 PL 2044076T3
- Authority
- PL
- Poland
- Prior art keywords
- asenapine
- preparation
- intermediate products
- products used
- products
- Prior art date
Links
- VSWBSWWIRNCQIJ-GJZGRUSLSA-N (R,R)-asenapine Chemical compound O1C2=CC=CC=C2[C@@H]2CN(C)C[C@H]2C2=CC(Cl)=CC=C21 VSWBSWWIRNCQIJ-GJZGRUSLSA-N 0.000 title 1
- 229960005245 asenapine Drugs 0.000 title 1
- 239000013067 intermediate product Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/24—Halogenated derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/017—Esters of hydroxy compounds having the esterified hydroxy group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06116660 | 2006-07-05 | ||
EP07801417A EP2044076B1 (en) | 2006-07-05 | 2007-07-03 | Process for the preparation of asenapine and intermediate products used in said process. |
PCT/EP2007/005876 WO2008003460A1 (en) | 2006-07-05 | 2007-07-03 | Process for the preparation of asenapine and intermediate products used in said process. |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2044076T3 true PL2044076T3 (pl) | 2010-03-31 |
Family
ID=37685865
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL07801417T PL2044076T3 (pl) | 2006-07-05 | 2007-07-03 | Sposób wytwarzania asenapiny i związki pośrednie do stosowania w tym sposobie |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP2044076B1 (pl) |
JP (1) | JP2010503611A (pl) |
CN (1) | CN101484456B (pl) |
AR (1) | AR061811A1 (pl) |
AT (1) | ATE445620T1 (pl) |
CA (1) | CA2655670A1 (pl) |
CY (1) | CY1109707T1 (pl) |
DE (1) | DE602007002826D1 (pl) |
DK (1) | DK2044076T3 (pl) |
ES (1) | ES2333488T3 (pl) |
HK (1) | HK1127044A1 (pl) |
MX (1) | MX2008016490A (pl) |
PL (1) | PL2044076T3 (pl) |
PT (1) | PT2044076E (pl) |
SI (1) | SI2044076T1 (pl) |
TW (1) | TW200817414A (pl) |
WO (1) | WO2008003460A1 (pl) |
ZA (1) | ZA200810859B (pl) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7875729B2 (en) * | 2007-01-05 | 2011-01-25 | Synthon Bv | Process for making asenapine |
CA2710800A1 (en) * | 2008-01-04 | 2009-07-16 | N.V. Organon | Process for the preparation of asenapine and intermediate products used in said process |
CN102596172A (zh) * | 2009-06-24 | 2012-07-18 | Msd欧斯股份有限公司 | 含有阿塞那平的注射剂和使用其的治疗方法 |
WO2012123325A1 (en) | 2011-03-11 | 2012-09-20 | Medichem S.A. | NEW CRYSTAL FORMS OF THE SALT OF TRANS-5-CHLORO-2-METHYL-2,3,3A,12b-TETRAHYDRO-1H-DIBENZO[2,3:6,7]OXEPINO[4,5-c]PYRROLE WITH MALEIC ACID |
CN102229613B (zh) * | 2011-04-27 | 2013-08-07 | 上海华升生物科技有限公司 | 阿森纳平的合成工艺 |
ITMI20110734A1 (it) * | 2011-05-02 | 2012-11-03 | Olon Spa | Sali cristallini di asenapina |
EP2524921A1 (en) * | 2011-05-17 | 2012-11-21 | Sandoz AG | Novel Crystalline Salts of Asenapine |
EP2524919A1 (en) | 2011-05-17 | 2012-11-21 | Sandoz AG | Novel crystalline salts of Asenapine with organic Di-acids and Tri-acids |
CN102952144A (zh) * | 2011-08-29 | 2013-03-06 | 上海华拓医药科技发展股份有限公司 | 阿森纳平马来酸盐的晶型、制备方法及其药物组合物 |
EP2572703A1 (en) | 2011-09-21 | 2013-03-27 | Hexal AG | Compressed oral dosage form for asenapine maleate |
WO2013041604A1 (en) | 2011-09-21 | 2013-03-28 | Sandoz Ag | Crystal form of asenapine maleate |
GB201121128D0 (en) * | 2011-12-08 | 2012-01-18 | Dow Corning | Treatment of filler with silane |
GB201121124D0 (en) * | 2011-12-08 | 2012-01-18 | Dow Corning | Hydrolysable silanes |
CN103183680A (zh) * | 2011-12-27 | 2013-07-03 | 上海华拓医药科技发展股份有限公司 | 阿森那平的制备方法 |
WO2013190481A1 (en) * | 2012-06-21 | 2013-12-27 | Alembic Pharmaceuticals Limited | Process for preparing asenapine and salts of intermediates thereof |
CN103772402A (zh) * | 2014-01-07 | 2014-05-07 | 万特制药(海南)有限公司 | 一种新的阿塞那平马来酸盐粗品精制方法 |
CN104974167B (zh) * | 2014-04-02 | 2019-01-04 | 洋浦慧谷医药有限公司 | 阿塞那平的制备方法以及用于制备阿塞那平的中间体 |
US10056563B2 (en) | 2016-04-08 | 2018-08-21 | Samsung Electronics Co., Ltd. | Synthetic method of fused heteroaromatic compound and fused heteroaromatic compound, and intermediate thereof |
KR102677490B1 (ko) | 2016-11-08 | 2024-06-20 | 삼성전자주식회사 | 축합 헤테로방향족 화합물의 합성 방법, 축합 헤테로방향족 화합물 및 그 중간체 및 합성 방법 |
PL3338768T3 (pl) | 2016-12-20 | 2020-05-18 | Lts Lohmann Therapie-Systeme Ag | Transdermalny system terapeutyczny zawierający asenapinę |
CA3047354A1 (en) | 2016-12-20 | 2018-06-28 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene |
CA3067938A1 (en) | 2017-06-26 | 2019-01-03 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer |
CA3101420A1 (en) | 2018-06-20 | 2019-12-26 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine |
CN110183457A (zh) * | 2019-06-27 | 2019-08-30 | 浙江天顺药业有限公司 | 一种阿塞那平及其制备方法 |
CN112830931A (zh) | 2019-08-13 | 2021-05-25 | 浙江奥翔药业股份有限公司 | 制备阿塞那平的方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7605526A (nl) * | 1976-05-24 | 1977-11-28 | Akzo Nv | Nieuwe tetracyclische derivaten. |
ATE447564T1 (de) * | 2005-04-07 | 2009-11-15 | Organon Nv | Zwischenprodukte für die herstellung von trans-5- chlor-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenzä , 3:6,7üoxepinoä4,5-cüpyrrol |
-
2007
- 2007-06-27 TW TW096123323A patent/TW200817414A/zh unknown
- 2007-07-03 DK DK07801417.2T patent/DK2044076T3/da active
- 2007-07-03 PL PL07801417T patent/PL2044076T3/pl unknown
- 2007-07-03 DE DE602007002826T patent/DE602007002826D1/de active Active
- 2007-07-03 CA CA002655670A patent/CA2655670A1/en not_active Abandoned
- 2007-07-03 ES ES07801417T patent/ES2333488T3/es active Active
- 2007-07-03 CN CN2007800254650A patent/CN101484456B/zh not_active Expired - Fee Related
- 2007-07-03 SI SI200730116T patent/SI2044076T1/sl unknown
- 2007-07-03 AT AT07801417T patent/ATE445620T1/de active
- 2007-07-03 EP EP07801417A patent/EP2044076B1/en active Active
- 2007-07-03 PT PT07801417T patent/PT2044076E/pt unknown
- 2007-07-03 WO PCT/EP2007/005876 patent/WO2008003460A1/en active Application Filing
- 2007-07-03 MX MX2008016490A patent/MX2008016490A/es active IP Right Grant
- 2007-07-03 JP JP2009517030A patent/JP2010503611A/ja not_active Withdrawn
- 2007-07-04 AR ARP070102980A patent/AR061811A1/es unknown
-
2008
- 2008-12-23 ZA ZA200810859A patent/ZA200810859B/xx unknown
-
2009
- 2009-07-14 HK HK09106284.3A patent/HK1127044A1/xx not_active IP Right Cessation
-
2010
- 2010-01-05 CY CY20101100007T patent/CY1109707T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CN101484456A (zh) | 2009-07-15 |
SI2044076T1 (sl) | 2010-01-29 |
EP2044076A1 (en) | 2009-04-08 |
CY1109707T1 (el) | 2014-04-09 |
HK1127044A1 (en) | 2009-09-18 |
WO2008003460A1 (en) | 2008-01-10 |
TW200817414A (en) | 2008-04-16 |
ATE445620T1 (de) | 2009-10-15 |
CA2655670A1 (en) | 2008-01-10 |
ZA200810859B (en) | 2009-09-30 |
PT2044076E (pt) | 2010-01-20 |
EP2044076B1 (en) | 2009-10-14 |
MX2008016490A (es) | 2009-01-22 |
DK2044076T3 (da) | 2010-02-01 |
AR061811A1 (es) | 2008-09-24 |
JP2010503611A (ja) | 2010-02-04 |
CN101484456B (zh) | 2011-09-07 |
ES2333488T3 (es) | 2010-02-22 |
DE602007002826D1 (de) | 2009-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI2044076T1 (sl) | Postopek za pripravo azenapina in vmesni produkti, uporabljeni v tem postopku | |
EP2035602A4 (en) | GALVANIZED PRODUCT AND MANUFACTURING METHOD THEREFOR | |
ZA200805939B (en) | Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments | |
IL198847A (en) | Process for making 2-imino-thiazolidine-4-on and several such histories | |
PL1922309T3 (pl) | Pochodne n-fenylo-2-pirymidynoaminy oraz sposób ich otrzymywania | |
HK1138517A1 (en) | Revaprazan-containing solid dispersion and process for the preparation thereof | |
HK1135852A1 (en) | Anti-biocontaminant products and processes for making the same | |
PL2096937T3 (pl) | Sposób wytwarzania produktów herbacianych o zwiększonej zawartości teaflawiny | |
IL193236A0 (en) | Novel pyrone-indole derivatives and process for their preparation | |
EP1895853A4 (en) | YOGHURT BEAUTY PRODUCTS AND METHOD OF PREPARING THEM | |
IL193339A0 (en) | Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments | |
LT1928255T (lt) | Pieno produktų gamybos būdas, tuo būdu gauti produktai ir jų panaudojimas | |
EP1834624A4 (en) | MEDICAL COMPOSITION AND MANUFACTURING METHOD THEREFOR | |
HK1131005A1 (zh) | 凝膠狀食品及其製造方法 | |
ZA200902899B (en) | Product and process | |
GB0714388D0 (en) | Process and product produced by the process | |
HK1126190A1 (en) | Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them | |
HU0500291D0 (en) | Fasteners, methods for making fasteners and use of fasteners in products | |
IL205446A0 (en) | Method of preparing (6r) - 3 - hexyl - 4 - hydroxy - 6 - undecyl - 5, 6 - dihydropyran - 2 - one, and intermediate used in the method | |
IL194737A0 (en) | 2-alkenyl-3-aminothiophene derivatives and processes for the preparation thereof | |
EP1958515A4 (en) | MILK PRODUCT AND METHOD FOR MANUFACTURING THE SAME | |
GB0613826D0 (en) | Process and product | |
ZA201004272B (en) | An improved process for the preparation of trans 3,4-diarylchroman and their derivatives | |
PL378347A1 (pl) | Sposób podwyższania parametrów fizyko-chemicznych paliw stałych i produkty powstałe w jego wyniku | |
AU2007902407A0 (en) | Improved dosage form and process |